VelocityTX’s vision for its campus and for a larger innovation district in East San Antonio predates the pandemic. More recent events, including the planned merger of UTSA and UT Health San Antonio, ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...

Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...

The authors of a new Bioelectronic Medicine study see potential in bioelectronic medical systems that continuously sense the patient's signals, then continuously modify treatment.

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

H.C. Wainwright & Co. reaffirmed its Buy rating and $15.00 price target for Emergent BioSolutions stock (NYSE:EBS). The ...

Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) ...